New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost
Clinical researchers studying germline disorders now have access to an extension of the highly referenced, Ion AmpliSeq next-generation sequencing (NGS) line of assays. The new Ion AmpliSeq On-Demand targeted sequencing panels for inherited disease research provide easy and practical design customization capabilities to lower upfront costs regardless of project size. Thermo Fisher Scientific will introduce... Read more